Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 5Drug Therapy 3Specimen Handling 2Immune Checkpoint Inhibitors 2Carboplatin 2Biopsy, Large-Core Needle 2Biopsy 2toripalimab 1tislelizumab 1taxane 1sacituzumab govitecan 1pembrolizumab 1atezolizumab 1Zoledronic Acid 1Urine Specimen Collection 1Prophylactic Mastectomy 1Paracentesis 1Neuropsychological Tests 1Mifepristone 1Medicine, Chinese Traditional 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunotherapy 1Immunohistochemistry 1Gene Expression Profiling 1Doxorubicin 1DNA 1Cyclophosphamide 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Triple Negative Breast Neoplasms × Zoledronic Acid × Clear all
NCT04045522 2021-07-20

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Shengjing Hospital

Unknown
120 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡